Approximately one in five people worldwide has elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial infarction and stroke.1The Roche Diagnostics ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

Due to nightlong cloud cover, the minimum temperature rose above the freezing point in Srinagar city on Wednesday as the MET ...

Flavonoids help the immune system by dampening down inflammation, but green tea is also packed full of epigallocatechin ...

The analysis indicates that while potatoes don't raise heart disease risk, fried varieties may contribute to higher ...

The AHA's 2025 report highlights alarming trends in cardiovascular disease, obesity, and lifestyle factors, emphasizing the ...

Over 80% of these fatalities result from heart attacks and strokes. December is notorious for being the biggest month for ...

Beta-blockers are widely used medications that help manage high blood pressure by reducing the heart rate and relaxing blood ...

A recent study indicates that individuals with HIV have a threefold increased risk of developing subclinical obstructive ...

The University of Cincinnati's Pooja Khatri spoke with Medscape on a new American Heart Association advisory recommending ...